TLDR Navan shares surged 19% following an earnings beat and upward revision to full-year projections Oracle shares declined 10% on capital raise concerns despite posting impressive quarterly
Equity futures posted solid gains Thursday morning as investors looked to recover from the previous session’s broad-based decline. Wednesday’s retreat was primarily attributed to weakness in artificial intelligence-related equities.
Market confidence strengthened after crude oil retreated from recent highs. Washington confirmed the conclusion of its retaliatory military operations against Iranian targets, which helped calm concerns about potential escalation in the Middle East.
S&P 500 futures climbed 0.60%, with Dow Jones futures advancing 0.69%. The benchmark 10-year Treasury note yield declined to 4.526%.
E-Mini S&P 500 Jun 26 (ES=F)During Wednesday’s regular trading hours, the S&P 500 index retreated 1.62% while the Dow Jones Industrial Average shed 1.87%. Overnight trading in Asian markets showed mixed results, with Japan’s Nikkei posting modest gains while China’s Shanghai Composite dipped lower.
Bitcoin climbed 1.93% to reach $63,095 during early morning hours. Gold futures decreased 0.64% while Brent crude oil dropped 1.17%.
Navan emerged as the session’s most impressive performer, with equity shares climbing 19% during pre-market hours.
The corporate travel and expense software provider unveiled first-quarter financial results that significantly exceeded Wall Street projections. Non-GAAP earnings reached $0.08 per share, surpassing analyst predictions by $0.07.
Quarterly revenue totaled $220.3 million, exceeding consensus forecasts by $15 million.
The company also upgraded its outlook for the full fiscal year. Management now projects fiscal 2027 revenue ranging from $907 million to $913 million, representing approximately 30% year-over-year expansion.
Profitability expectations also received an upgrade, with non-GAAP operating income now anticipated between $76 million and $80 million.
AXT shares rose 7.3% in early trading. Spyre Therapeutics, Coupang, and Tower Semiconductor each registered gains exceeding 6%.
Oracle ranked among the morning’s weakest performers, sliding approximately 10% even after delivering robust quarterly performance.
Fourth-quarter revenue increased 21% from the prior year to reach $19.2 billion. Adjusted earnings of $2.11 per share exceeded analyst expectations.
Cloud infrastructure revenue soared 93%, while total cloud services revenue jumped 47%. The enterprise software giant also disclosed a $638 billion remaining performance obligation backlog, fueled by substantial AI-related contracts.
Oracle projected fiscal 2027 revenue of $90 billion, surpassing Wall Street’s forecasts.
Despite these positive metrics, shareholders sent the stock lower. Primary concerns centered on declining legacy software revenue and management’s announcement of plans to raise $40 billion through combined debt and equity offerings to finance AI data center expansion.
Humacyte shares dropped 16% after announcing a public offering of 47.6 million shares priced at $1.05 per share, generating approximately $50 million in gross proceeds.
PureCycle shares declined 14% following disclosure of $395 million in combined capital raising activities, including $250 million in convertible senior notes and an equity offering priced at $8.21 per share.
The post Market Movers Alert: Navan Jumps 19% as Oracle (ORCL) Tumbles Despite Strong Quarter appeared first on Blockonomi.
